Mr Dmitriev said clinical trials of the drug had been conducted involving 330 people, and had shown it successfully treated the virus in most cases within four days.
Clinical trials to test the efficacy of drugs usually take many months, even when expedited, and involve large numbers of patients randomly assigned who receive either the drug being trialled or a placebo. Mr Dmitriev said Russia was able to cut testing timescales because the Japanese generic drug which Avifavir is based on was first registered in 2014 and had undergone significant testing before Russian specialists modified it.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: YahooSG - 🏆 3. / 71 Read more »